ABVC (ABVC BioPharma) Insider Ownership: 61.46 % (As of Jul. 13, 2026)


ABVC ABVC BioPharma Inc ABVC
17 GF Score
Price $1.51
GF Value $0.87
Valuation Significantly Overvalued
! 1 Warning Sign
View Full Analysis

What is ABVC BioPharma Insider Ownership?

ABVC BioPharma ABVC +3.42% 17 Insider Ownership is 61.46 % as of Jul. 13, 2026. GuruFocus rates ABVC with a GF Score™ of 17/100 and a GF Value™ of $0.87 (Significantly Overvalued). The stock has 1 warning sign investors should review.

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, ABVC BioPharma's insider ownership is 61.46%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, ABVC BioPharma's Institutional Ownership is 4.25%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, ABVC BioPharma's Float Percentage Of Total Shares Outstanding is 81.43%.

ABVC BioPharma Insider Ownership Historical Data

* Premium members only.

The historical data trend for ABVC BioPharma's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ABVC BioPharma Insider Ownership Chart

ABVC BioPharma Historical Data

The historical data trend for ABVC BioPharma can be seen below:

2025-06-30 2025-07-31 2025-08-31 2025-09-30 2025-10-31 2025-11-30 2026-01-31 2026-02-28 2026-05-31 2026-06-30
Insider Ownership 92.79 92.79 66.94 66.94 66.94 64.84 64.84 64.84 61.46 61.46
ABVC
17GF Score
ABVC BioPharma Inc ABVC
Insider Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ABVC BioPharma Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.

Frequently Asked Questions Learn more about Insider Ownership →
What does a Insider Ownership of 61.46 % mean?
ABVC BioPharma (ABVC) has a Insider Ownership of 61.46 % as of Jul. 13, 2026. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on ABVC BioPharma and its competitors.
Is ABVC BioPharma's Insider Ownership too high?
ABVC BioPharma's current Insider Ownership is 61.46 %. Overall, ABVC BioPharma has a GF Score™ of 17/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does ABVC BioPharma's Insider Ownership compare to GRCE and ELOX?
ABVC BioPharma's Insider Ownership of 61.46 % can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Insider Ownership for a Biotechnology company?
A good Insider Ownership depends on the Biotechnology industry context. However, Insider Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Insider Ownership mean?
A high Insider Ownership can signal that a stock is expensive relative to its fundamentals. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on ABVC BioPharma and its competitors. ABVC BioPharma's current Insider Ownership is 61.46 %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ABVC BioPharma stock overvalued right now?
Based on GuruFocus' analysis, ABVC BioPharma (ABVC) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.87, compared to a current price of $1.51 — trading 73.6% above its estimated fair value. The current Insider Ownership is 61.46 %. ABVC BioPharma's overall GF Score™ is 17/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Insider Ownership calculated?
Insider Ownership is calculated from a company's financial statements. For ABVC BioPharma (ABVC), the current Insider Ownership is 61.46 % as of Jul. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is ABVC BioPharma (ABVC) Overvalued in 2026?

Based on GuruFocus' analysis, ABVC BioPharma stock appears to be overvalued. The current stock price of $1.51 is trading 73.6% above its estimated GF Value™ of $0.87. GuruFocus considers ABVC BioPharma to be Significantly Overvalued.

Key valuation signals for ABVC:

  • Insider Ownership: 61.46 %
  • GF Value™: $0.87 vs. price of $1.51 (73.6% above fair value)
  • GF Score™: 17/100 with 1 warning sign

No single metric tells the full story. See the ABVC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

ABVC BioPharma Business Description

Address 44370 Old Warm Springs Boulevard, Fremont, CA, USA, 94538
ABVC BioPharma Inc is a clinical stage biopharmaceutical company focused on development of new drugs and medical devices, all of which are derived from plants. It currently has six drugs and three medical devices in development. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes. Its products include: Vitargus - ABV-1701, ABV-2001, ABV-2002, MDD ABV-1504, ADHD ABV-1505, ADHD ABV-1601, ABV-1501, ABV-1702, and ABV-1703.
17GF Score

Get the complete analysis for ABVC

Insider Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.51
Price
$0.87
GF Value